Get the Stockscreener App
1.42
4.41%
0.06
Pre-market:
1.41
-0.01
-0.70%
Hoth Therapeutics Inc stock is traded at $1.42, with a volume of 210.59K.
It is up +4.41% in the last 24 hours and down -12.35% over the past month.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
See More
Previous Close:
$1.36
Open:
$1.36
24h Volume:
210.59K
Relative Volume:
0.19
Market Cap:
$18.83M
Revenue:
-
Net Income/Loss:
$-7.51M
P/E Ratio:
-1.0758
EPS:
-1.32
Net Cash Flow:
$-8.02M
1W Performance:
+3.65%
1M Performance:
-12.35%
6M Performance:
+57.95%
1Y Performance:
+67.06%
1-Day Range:
$1.36
$1.42
1-Week Range:
$1.3401
$1.4702
52-Week Range:
$0.6554
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Name
Hoth Therapeutics Inc
Sector
Industry
Phone
(646)756-2997
Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Compare HOTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.42 | 18.03M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-19 | Initiated | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Stock (HOTH) Latest News
Will Hoth Therapeutics Inc. rebound enough to break even2025 Retail Activity & Daily Profit Focused Stock Screening - newser.com
Why Hoth Therapeutics Inc. stock remains on buy listsPortfolio Risk Report & Smart Swing Trading Alerts - newser.com
Will Hoth Therapeutics Inc. stock outperform international peers2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Why hedge funds are buying Hoth Therapeutics Inc. stock2025 Winners & Losers & Weekly Return Optimization Alerts - newser.com
Strategies to average down on Hoth Therapeutics Inc.Stop Loss & Verified Momentum Stock Watchlist - newser.com
How to build a dashboard for Hoth Therapeutics Inc. stock2025 AllTime Highs & Intraday High Probability Alerts - newser.com
Using Python tools to backtest Hoth Therapeutics Inc. strategiesTrade Risk Assessment & Daily Technical Forecast Reports - newser.com
Should you hold or exit Hoth Therapeutics Inc. nowGap Up & Free High Accuracy Swing Entry Alerts - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyInflation Watch & Target Return Focused Picks - newser.com
Is Hoth Therapeutics Inc. stock attractive for ETFs2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
Will Hoth Therapeutics Inc. stock gain from strong economy2025 Year in Review & Real-Time Buy Zone Alerts - newser.com
Can momentum traders help lift Hoth Therapeutics Inc.July 2025 Analyst Calls & Weekly High Momentum Picks - newser.com
Published on: 2025-10-30 00:33:14 - newser.com
2 Stocks to Buy Under $10 That Wall Street Loves - Barchart.com
Published on: 2025-10-28 22:41:09 - newser.com
How Hoth Therapeutics Inc. stock performs in interest rate cyclesJuly 2025 Breakouts & Weekly Return Optimization Alerts - fcp.pa.gov.br
Published on: 2025-10-27 23:37:27 - newser.com
Hoth Therapeutics Inc Stock (HOTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):